Kincell Bio, a cell therapy contract development and manufacturing organization (CDMO), has announced a new multi-year partnership with a clinical-stage cell therapy company. The agreement will see Kincell Bio produce patient-specific batches of clinical-grade product at its Gainesville, Florida facility.   This new contract adds to Kincell Bio’s growing portfolio of cell therapy projects, solidifying its position as a trusted partner in the industry. The company’s GMP-ready facili...